1. Home
  2. UG vs DARE Comparison

UG vs DARE Comparison

Compare UG & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$6.62

Market Cap

27.7M

ML Signal

HOLD

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$1.72

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
DARE
Founded
1942
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
24.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UG
DARE
Price
$6.62
$1.72
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
14.9K
76.3K
Earning Date
03-20-2026
03-30-2026
Dividend Yield
7.47%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$10,060,322.00
N/A
Revenue This Year
N/A
$3,843.33
Revenue Next Year
N/A
$8,700.33
P/E Ratio
$15.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.58
$1.61
52 Week High
$11.08
$9.19

Technical Indicators

Market Signals
Indicator
UG
DARE
Relative Strength Index (RSI) 49.31 38.07
Support Level $6.25 $1.68
Resistance Level $7.41 $2.02
Average True Range (ATR) 0.31 0.09
MACD -0.04 -0.02
Stochastic Oscillator 32.58 16.06

Price Performance

Historical Comparison
UG
DARE

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: